Marek Niedziela1, Nelly Sabbaghian2, Leanne de Kock2,3, William D Foulkes2,3. 1. Department of Pediatric Endocrinology and Rheumatology, Poznan University of Medical Sciences, Poznan, Poland. 2. Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Québec, Canada. 3. Department of Human Genetics, McGill University, Montreal, Québec, Canada.
Abstract
INTRODUCTION: With the use of ultrasonography for the evaluation of thyroid and nonthyroid neck diseases, the incidental discovery of previously unsuspected thyroid nodules/nonpalpable lesions has increased. Intrathyroidal thymus arises due to aberrant thymic migration during embryogenesis. It is thought to be rare, fulfils the classiccriteria for diagnosis of an incidentaloma and it can be mistaken for a thyroid nodule. Multinodular goiter is the main endocrine manifestation of DICER1 syndrome, a tumor predisposition syndrome. Careful thyroid examination including ultrasound is thus necessary for DICER1 syndrome patients. CASE REPORT: A 4-year-old prepubertal boy was referred to the pediatric endocrinology department following an earlier diagnosis of pleuropulmonary blastoma (PPB) type III, which is a hallmark component of DICER1 syndrome. The patient underwent surgery followed by chemotherapy. Genetic analysis identified a germline DICER1 pathogenic variant (c.2062C>T, p.R688*)in the child and in 5 relatives. A second somatic DICER1 RNase IIIb hotspot mutation(c.5438A>G, p.E1813G) was identified in DNA extracted from the proband's PPB. He had no goiter on clinical examination, but a heterogenous, well-delineated, avascular, solid and hypoechogenic lesion with pseudomicrocalcifications was observed in the right lobe (4.1 × 3.1 × 2.6 mm), suggestive of thyroid neoplasia. Diagnostic work-up and a 3-year follow-up excluded thyroid neoplasia and confirmed the diagnosis of an intrathyroid benign thymic lesion. DISCUSSION AND CONCLUSION: This case exemplifies that thyroid incidentalomas in DICER1 syndrome patients should be viewed with great suspicion, but that not all thyroid disorders are indeed DICER1-related in these patients.
INTRODUCTION: With the use of ultrasonography for the evaluation of thyroid and nonthyroid neck diseases, the incidental discovery of previously unsuspected thyroid nodules/nonpalpable lesions has increased. Intrathyroidal thymus arises due to aberrant thymic migration during embryogenesis. It is thought to be rare, fulfils the classiccriteria for diagnosis of an incidentaloma and it can be mistaken for a thyroid nodule. Multinodular goiter is the main endocrine manifestation of DICER1 syndrome, a tumor predisposition syndrome. Careful thyroid examination including ultrasound is thus necessary for DICER1 syndrome patients. CASE REPORT: A 4-year-old prepubertal boy was referred to the pediatric endocrinology department following an earlier diagnosis of pleuropulmonary blastoma (PPB) type III, which is a hallmark component of DICER1 syndrome. The patient underwent surgery followed by chemotherapy. Genetic analysis identified a germline DICER1 pathogenic variant (c.2062C>T, p.R688*)in the child and in 5 relatives. A second somatic DICER1 RNase IIIb hotspot mutation(c.5438A>G, p.E1813G) was identified in DNA extracted from the proband's PPB. He had no goiter on clinical examination, but a heterogenous, well-delineated, avascular, solid and hypoechogenic lesion with pseudomicrocalcifications was observed in the right lobe (4.1 × 3.1 × 2.6 mm), suggestive of thyroid neoplasia. Diagnostic work-up and a 3-year follow-up excluded thyroid neoplasia and confirmed the diagnosis of an intrathyroid benign thymic lesion. DISCUSSION AND CONCLUSION: This case exemplifies that thyroid incidentalomas in DICER1 syndrome patients should be viewed with great suspicion, but that not all thyroid disorders are indeed DICER1-related in these patients.
Authors: Mizuki Nishino; Simon K Ashiku; Olivier N Kocher; Robert L Thurer; Phillip M Boiselle; Hiroto Hatabu Journal: Radiographics Date: 2006 Mar-Apr Impact factor: 5.333
Authors: Adnan Kabaalioğlu; Murat Alp Öztek; Uğur Kesimal; Kağan Çeken; Emel Durmaz; Ali Apaydın Journal: Med Ultrason Date: 2017-04-22 Impact factor: 1.611
Authors: Thomas Rio Frio; Amin Bahubeshi; Chryssa Kanellopoulou; Nancy Hamel; Marek Niedziela; Nelly Sabbaghian; Carly Pouchet; Lucy Gilbert; Paul K O'Brien; Kim Serfas; Peter Broderick; Richard S Houlston; Fabienne Lesueur; Elena Bonora; Stefan Muljo; R Neil Schimke; Dorothée Bouron-Dal Soglio; Jocelyne Arseneau; Kris Ann Schultz; John R Priest; Van-Hung Nguyen; H Rubén Harach; David M Livingston; William D Foulkes; Marc Tischkowitz Journal: JAMA Date: 2011-01-05 Impact factor: 56.272
Authors: Emily Kay-Rivest; Marco A Mascarella; Pramod Puligandla; Sherif Emil; Christine Saint-Martin; Lily H P Nguyen; Sam J Daniel; Robert Baird Journal: J Pediatr Surg Date: 2018-02-08 Impact factor: 2.545
Authors: D Ashley Hill; Jennifer Ivanovich; John R Priest; Christina A Gurnett; Louis P Dehner; David Desruisseau; Jason A Jarzembowski; Kathryn A Wikenheiser-Brokamp; Brian K Suarez; Alison J Whelan; Gretchen Williams; Dawn Bracamontes; Yoav Messinger; Paul J Goodfellow Journal: Science Date: 2009-06-25 Impact factor: 47.728
Authors: Ingrid Slade; Chiara Bacchelli; Helen Davies; Anne Murray; Fatemeh Abbaszadeh; Sandra Hanks; Rita Barfoot; Amos Burke; Julia Chisholm; Martin Hewitt; Helen Jenkinson; Derek King; Bruce Morland; Barry Pizer; Katrina Prescott; Anand Saggar; Lucy Side; Heidi Traunecker; Sucheta Vaidya; Paul Ward; P Andrew Futreal; Gordan Vujanic; Andrew G Nicholson; Neil Sebire; Clare Turnbull; John R Priest; Kathryn Pritchard-Jones; Richard Houlston; Charles Stiller; Michael R Stratton; Jenny Douglas; Nazneen Rahman Journal: J Med Genet Date: 2011-01-25 Impact factor: 6.318
Authors: Nicholas E Khan; Andrew J Bauer; Kris Ann P Schultz; Leslie Doros; Rosamma M Decastro; Alexander Ling; Maya B Lodish; Laura A Harney; Ron G Kase; Ann G Carr; Christopher T Rossi; Amanda Field; Anne K Harris; Gretchen M Williams; Louis P Dehner; Yoav H Messinger; D Ashley Hill; Douglas R Stewart Journal: J Clin Endocrinol Metab Date: 2017-05-01 Impact factor: 5.958